Taysha Gene Therapies Inc. (TSHA) NASDAQ
$2.53 0.07 (2.64%)
Market Cap: $460.06M
As of 04/23/24 03:59 PM EDT. Market closed.
Taysha Gene Therapies Inc. (TSHA)
NASDAQ
$2.53
0.07 (2.64%)
Market Cap: $460.06M
As of 04/23/24 03:59 PM EDT. Market closed.
Add to Portfolio
taysha gene therapies, inc., a gene therapy company, develops adeno-associated virus based gene therapies for the treatment of monogenic diseases of the central nervous system. it primarily develops tsha-101 for the treatment of gm2 gangliosidosis; tsha-118 for the treatment of cln1 disease; tsha-102 for the treatment of rett syndrome; tsha-103 for the treatment of slc6a1 haploinsufficiency ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
96
Address
.
PRICE CHART FOR TAYSHA GENE THERAPIES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.55
Previous Close
$2.46
Days Range
$2.20 - $2.46
52 week range
$0.50 - $3.89
Volume
1,458,646
Avg. Volume (30 days)
2,136,011
Market Cap
$460.06M
Dividend Yield
-
P/E
(4.12)
Shares Outstanding
187,018,275
Open
$2.55
Previous Close
$2.46
Days Range
$2.20 - $2.46
52 week range
$0.50 - $3.89
Volume
1,458,646
Avg. Volume (30 days)
2,136,011
Market Cap
$460.06M
Dividend Yield
-
P/E
(4.12)
Shares Outstanding
187,018,275
FINANCIAL STATEMENTS FOR TAYSHA GENE THERAPIES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR TAYSHA GENE THERAPIES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Alam Kamran | CHIEF FINANCIAL OFFICER | Feb 02, 2024 | Option Exercise | $1.51 | 1,288 | 1,945 | 840,937 | Feb 06, 2024, 04:42 PM |
| Manning Paul B | 10% Owner | Nov 17, 2023 | Buy | $1.63 | 100,000 | 163,000 | 16,566,667 | Nov 20, 2023, 07:35 AM |
| Alam Kamran | Chief Financial Officer | Aug 24, 2023 | Sale | $2.33 | 33,000 | 76,890 | 258,042 | Aug 25, 2023, 04:30 PM |
| Manning Paul B | 10% Owner | Aug 16, 2023 | Buy | $0.90 | 16,466,667 | 14,820,000 | 16,466,667 | Aug 16, 2023, 08:57 PM |
| Stalfort John A III | Director | Aug 16, 2023 | Buy | $0.90 | 388,889 | 350,000 | 999,381 | Aug 16, 2023, 08:53 PM |
| Stalfort John A III | Director | Aug 16, 2023 | Buy | $0.90 | 388,889 | 350,000 | 884,290 | Aug 16, 2023, 08:53 PM |
| Nolan Sean P. | Chief Executive Officer | Aug 16, 2023 | Buy | $0.90 | 444,444 | 400,000 | 1,535,545 | Aug 16, 2023, 08:52 PM |
| Donenberg Phillip B. | Director | Aug 16, 2023 | Buy | $0.90 | 111,111 | 100,000 | 114,111 | Aug 16, 2023, 08:51 PM |
| Session R.A. II | 10% Owner | Jul 13, 2023 | Sale | $0.70 | 5,344 | 3,741 | 8,871,747 | Jul 14, 2023, 04:00 PM |
| Session R.A. II | 10% Owner | Jul 12, 2023 | Sale | $0.71 | 80,528 | 57,030 | 8,877,091 | Jul 14, 2023, 04:00 PM |
| Session R.A. II | 10% Owner | Jun 23, 2023 | Sale | $0.70 | 18,100 | 12,735 | 8,957,619 | Jun 26, 2023, 04:46 PM |
| Session R.A. II | 10% Owner | Jun 22, 2023 | Sale | $0.70 | 10,508 | 7,384 | 8,975,719 | Jun 26, 2023, 04:46 PM |
| Session R.A. II | 10% Owner | Jun 21, 2023 | Sale | $0.70 | 138,962 | 97,635 | 8,986,227 | Jun 22, 2023, 04:00 PM |
| Session R.A. II | 10% Owner | Jun 20, 2023 | Sale | $0.71 | 295,653 | 210,209 | 9,125,189 | Jun 22, 2023, 04:00 PM |
| Nagendran Sukumar | President and Head of R&D | May 16, 2023 | Buy | $0.68 | 5,000 | 3,400 | 34,226 | May 18, 2023, 04:44 PM |
| Manning Paul B | Director | Oct 31, 2022 | Buy | $2.00 | 1,500,000 | 3,000,000 | 1,642,202 | Nov 02, 2022, 04:09 PM |
| Alam Kamran | Chief Financial Officer | Aug 23, 2022 | Sale | $3.47 | 3,325 | 11,538 | 266,121 | Aug 24, 2022, 04:47 PM |
| Alam Kamran | Chief Financial Officer | Aug 22, 2022 | Sale | $3.50 | 9,717 | 34,010 | 269,446 | Aug 22, 2022, 08:05 PM |
| Alam Kamran | Chief Financial Officer | Aug 19, 2022 | Sale | $3.75 | 11,482 | 43,058 | 279,163 | Aug 22, 2022, 08:05 PM |
| Alam Kamran | Chief Financial Officer | Aug 18, 2022 | Sale | $3.87 | 7,476 | 28,932 | 290,645 | Aug 22, 2022, 08:05 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jul 06, 2022 | Sale | $3.79 | 8,956 | 33,943 | 530,589 | Jul 07, 2022, 04:30 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jul 05, 2022 | Sale | $3.51 | 3,905 | 13,707 | 539,545 | Jul 07, 2022, 04:30 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jun 30, 2022 | Sale | $3.72 | 13,892 | 51,678 | 567,373 | Jul 01, 2022, 06:55 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jun 29, 2022 | Sale | $3.81 | 12,324 | 46,954 | 581,265 | Jul 01, 2022, 06:55 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jul 01, 2022 | Sale | $3.53 | 23,923 | 84,448 | 543,450 | Jul 01, 2022, 06:55 PM |
| Manning Paul B | Director | Feb 03, 2022 | Buy | $7.84 | 26,602 | 208,560 | 2,091,704 | Feb 04, 2022, 08:28 AM |
| Manning Paul B | Director | Feb 03, 2022 | Buy | $7.84 | 50,000 | 392,000 | 142,202 | Feb 04, 2022, 08:28 AM |
| Manning Paul B | Director | Feb 02, 2022 | Buy | $7.77 | 67,000 | 520,590 | 2,065,102 | Feb 04, 2022, 08:28 AM |
| Manning Paul B | Director | Feb 02, 2022 | Buy | $7.77 | 58,000 | 450,660 | 92,202 | Feb 04, 2022, 08:28 AM |
| Nagendran Sukumar | Director | Feb 02, 2022 | Buy | $8.01 | 10,000 | 80,100 | 29,226 | Feb 03, 2022, 09:21 AM |
| Donenberg Phillip B. | Director | Feb 02, 2022 | Buy | $7.78 | 3,000 | 23,340 | 3,000 | Feb 03, 2022, 07:04 AM |
| Session R.A. II | President and CEO | Nov 23, 2021 | Buy | $12.44 | 42,518 | 529,102 | 9,190,920 | Dec 08, 2021, 04:05 PM |
| Manning Paul B | Director | Nov 24, 2021 | Buy | $13.19 | 2,202 | 29,044 | 34,202 | Nov 29, 2021, 05:01 PM |
| Manning Paul B | Director | Nov 23, 2021 | Buy | $12.54 | 20,000 | 250,800 | 32,000 | Nov 24, 2021, 07:58 AM |
| Alam Kamran | Chief Financial Officer | Aug 19, 2021 | Sale | $16.47 | 9,967 | 164,175 | 310,574 | Aug 20, 2021, 05:52 PM |
| Alam Kamran | Chief Financial Officer | Aug 18, 2021 | Sale | $17.35 | 11,193 | 194,199 | 319,928 | Aug 20, 2021, 05:52 PM |
| Alam Kamran | Chief Financial Officer | Aug 20, 2021 | Sale | $16.78 | 11,840 | 198,649 | 300,215 | Aug 20, 2021, 05:52 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jul 01, 2021 | Sale | $21.12 | 19,706 | 416,191 | 593,589 | Jul 01, 2021, 06:32 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jun 30, 2021 | Sale | $21.79 | 20,076 | 437,494 | 619,997 | Jul 01, 2021, 06:32 PM |
| PRASAD SUYASH | CMO and Head of R&D | Jun 29, 2021 | Sale | $23.82 | 39,218 | 934,251 | 637,533 | Jul 01, 2021, 06:32 PM |
| Manning Paul B | Director | May 14, 2021 | Buy | $20.98 | 12,000 | 251,760 | 12,000 | May 17, 2021, 07:48 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Alam Kamran | CHIEF FINANCIAL OFFICER | 02/02/2024 | 1,945 |
| Manning Paul B | 10% Owner | 11/17/2023 | 163,000 |
| Alam Kamran | Chief Financial Officer | 08/24/2023 | 76,890 |
| Manning Paul B | 10% Owner | 08/16/2023 | 14,820,000 |
| Stalfort John A III | Director | 08/16/2023 | 350,000 |
| Stalfort John A III | Director | 08/16/2023 | 350,000 |
| Nolan Sean P. | Chief Executive Officer | 08/16/2023 | 400,000 |
| Donenberg Phillip B. | Director | 08/16/2023 | 100,000 |
| Session R.A. II | 10% Owner | 07/13/2023 | 3,741 |
| Session R.A. II | 10% Owner | 07/12/2023 | 57,030 |
| Session R.A. II | 10% Owner | 06/23/2023 | 12,735 |
| Session R.A. II | 10% Owner | 06/22/2023 | 7,384 |
| Session R.A. II | 10% Owner | 06/21/2023 | 97,635 |
| Session R.A. II | 10% Owner | 06/20/2023 | 210,209 |
| Nagendran Sukumar | President and Head of R&D | 05/16/2023 | 3,400 |
| Manning Paul B | Director | 10/31/2022 | 3,000,000 |
| Alam Kamran | Chief Financial Officer | 08/23/2022 | 11,538 |
| Alam Kamran | Chief Financial Officer | 08/22/2022 | 34,010 |
| Alam Kamran | Chief Financial Officer | 08/19/2022 | 43,058 |
| Alam Kamran | Chief Financial Officer | 08/18/2022 | 28,932 |
| PRASAD SUYASH | CMO and Head of R&D | 07/06/2022 | 33,943 |
| PRASAD SUYASH | CMO and Head of R&D | 07/05/2022 | 13,707 |
| PRASAD SUYASH | CMO and Head of R&D | 06/30/2022 | 51,678 |
| PRASAD SUYASH | CMO and Head of R&D | 06/29/2022 | 46,954 |
| PRASAD SUYASH | CMO and Head of R&D | 07/01/2022 | 84,448 |
| Manning Paul B | Director | 02/03/2022 | 208,560 |
| Manning Paul B | Director | 02/03/2022 | 392,000 |
| Manning Paul B | Director | 02/02/2022 | 520,590 |
| Manning Paul B | Director | 02/02/2022 | 450,660 |
| Nagendran Sukumar | Director | 02/02/2022 | 80,100 |
| Donenberg Phillip B. | Director | 02/02/2022 | 23,340 |
| Session R.A. II | President and CEO | 11/23/2021 | 529,102 |
| Manning Paul B | Director | 11/24/2021 | 29,044 |
| Manning Paul B | Director | 11/23/2021 | 250,800 |
| Alam Kamran | Chief Financial Officer | 08/19/2021 | 164,175 |
| Alam Kamran | Chief Financial Officer | 08/18/2021 | 194,199 |
| Alam Kamran | Chief Financial Officer | 08/20/2021 | 198,649 |
| PRASAD SUYASH | CMO and Head of R&D | 07/01/2021 | 416,191 |
| PRASAD SUYASH | CMO and Head of R&D | 06/30/2021 | 437,494 |
| PRASAD SUYASH | CMO and Head of R&D | 06/29/2021 | 934,251 |
| Manning Paul B | Director | 05/14/2021 | 251,760 |
Load More Insider Transactions
FUNDS WITH A POSITION IN TAYSHA GENE THERAPIES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 18,472,503 | 0.51% | No change | Other |
| BAKER BROS. ADVISORS LP | 4,004,756 | 0.08% | 59.89% | Other |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,700,000 | 0.98% | 146.67% | Growth, Growth At A Reasonable Price |
| BLACKROCK INC. | 2,699,238 | 0.00012% | 260.83% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 1,097,400 | 0.00301% | 83.51% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 985,421 | 0.00018% | 113.45% | Other |
| PALO ALTO INVESTORS LP | 529,861 | 0.08% | New | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 420,000 | 0.00154% | -72% | Other |
CHANGE IN SHARES OUTSTANDING FOR TAYSHA GENE THERAPIES INC
STOCK BUYBACKS FOR TAYSHA GENE THERAPIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-7.62%
1Q
BUYBACK ANNOUNCEMENT(S) FOR TAYSHA GENE THERAPIES INC
LOADING...